Abstract:Autosomal dominant Alzheimer's Disease (ADAD) mutation carriers will develop early-onset Alzheimer's disease (AD) in the future with near 100% certainty and provide a unique opportunity to characterize the earliest biological changes associated with the predisposition to develop AD. We previously reported that presenilin-1 (PSEN1) E280A mutation–carrying children from the world's largest ADAD kindred in Colombia have structural and functional connectivity MRI abnormalities, along with plasma biomarker findings consistent with Aβ1–42 overproduction. In this study, cross-sectional measures of cognitive, behavioral and socio-emotional functioning were assessed in PSEN1 mutation–carrying children, decades before the kindred's estimated median age 44 of mild cognitive impairment. Two-hundred-sixteen children (108 PSEN1 E280A carriers, 108 non-carriers), aged 8 to 17 years, were recruited from the Alzheimer's Prevention Initiative Colombia Registry. Participants were administered the Evaluacion Neuropsicologica Infantil-ENI, assessing memory, language and attention/executive function, and the Wechsler Intelligence Scale for Children-IV (WISC-IV), measuring general intelligence (verbal and non-verbal abilities, working memory, and processing speed). Parent-Child dyads completed the Behavior Assessment System for Children-2, assessing socio-emotional and behavioral functioning. Families and raters remained blind to the participant's genetic test results. Regression models examined the associations between cognitive and behavioral measurements and age in the mutation carrier and non-carrier groups. Compared to non-carriers, PSEN1 mutation carriers had lower mean scores on the WISC-IV Verbal Comprehension (p=0.01) and Processing Speed domains (p=0.04). Self-report measures revealed lower mean scores for carriers in Interpersonal Relations, skills which are necessary for interacting successfully with peers and adults (p=0.04). Age-associated differences between groups were seen in ENI subtests of attention (p=0.02). There were no differences in memory, complex attention, executive function or other cognitive domains. Results describe the earliest known cognitive and social vulnerabilities associated with ADAD. Findings suggest that children at genetic risk for ADAD have verbal, attention, and social vulnerabilities, even before the kindred's previously reported ages of 23 and 28 at the respective onset of CSF and PET indicators of fibrillar amyloid-β deposition. It remains to be clarified whether each of these alterations are developmental or reflective of the earliest progressive changes associated with preclinical AD.

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases

A heterozygous de novo PSEN1 mutation in a patient with early-onset parkinsonism

Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening

Two Novel Mutations and a De Novo Mutation in PSEN1 in Early-onset Alzheimer’s Disease

P3‐120: MOLECULAR GENETIC ANALYSIS OF APP, PSEN1, AND PSEN2 GENES IN CHINESE PATIENTS WITH ALZHEIMER'S DISEASE

Amyloid-β1–43 cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease

Genetic analyses of early-onset Alzheimer’s disease using next generation sequencing

The identification of PSEN1 p.Tyr159Ser mutation in a non-canonic early-onset Alzheimer's disease family

Clinical and genetic characteristics in a central-southern Chinese cohort of early-onset Alzheimer's disease

Screening and Functional Validations of APP, PSEN1 and PSEN2 Mutations from PUMCH Dementia Cohort

Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2

Novel mutations and repeated findings of mutations in familial Alzheimer disease

P2‐017: Mutation Frequency of Pathogenic Genes in Familial Alzheimer's Disease in China

Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism

Patient with PSEN1 Glu318Gly and Other Possible Disease Risk Mutations, Diagnosed with Early Onset Alzheimer's Disease

Identification of PSEN1 and APP Gene Mutations in Korean Patients with Early-Onset Alzheimer's Disease

De novo deleterious genetic variations target a biological network centered on Aβ peptide in early-onset Alzheimer disease

[O1–13–02]: COGNITIVE VULNERABILITIES IN PRESENILIN‐1 E280A MUTATION‐CARRYING CHILDREN FROM THE WORLD's LARGEST AUTOSOMAL‐DOMINANT ALZHEIMER's DISEASE KINDRED

PSEN2 Mutations May Mimic Frontotemporal Dementia: Two New Case Reports and a Review

Genetic Aspects of Alzheimer Disease